Scandicane en es it fr

Scandicane Brand names, Scandicane Analogs

Scandicane Brand Names Mixture

  • No information avaliable

Scandicane Chemical_Formula


Scandicane RX_link

Scandicane fda sheet

Scandicane FDA

Scandicane msds (material safety sheet)

Scandicane MSDS

Scandicane Synthesis Reference

No information avaliable

Scandicane Molecular Weight

129.164 g/mol

Scandicane Melting Point

223-226 oC

Scandicane H2O Solubility

Freely soluble as HCl salt

Scandicane State


Scandicane LogP


Scandicane Dosage Forms

Extended release tablet (500 mg or 1000 mg)

Scandicane Indication

For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.

Scandicane Pharmacology

Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.

Scandicane Absorption

Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.

Scandicane side effects and Toxicity

Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.

Scandicane Patient Information

Scandicane Organisms Affected

Humans and other mammals